PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection

2013-04-27
(Press-News.org) A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells. In a study conducted at Texas Biomed's Southwest National Primate Research Center, researchers found that the immune modulator GS-9620, which targets a receptor on immune cells, reduced both the virus levels and the number of infected liver cells in chimpanzees chronically infected with hepatitis B virus (HBV). Chimpanzees are the only species other than humans that can be infected by HBV. Therefore, the results from this study were critical in moving the drug forward to human clinical trials which are now in progress. The new report, co-authored by scientists from Texas Biomed and Gilead Sciences, appears in the May issue of Gastroenterology. Gilead researchers had previously demonstrated that the same therapy could induce a cure of hepatitis infection in woodchucks that were chronically infected with a virus similar to human HBV. "This is an important proof-of-concept study demonstrating that the therapy stimulates the immune system to suppress the virus and eliminate infected liver cells," said co-author Robert E. Lanford, Ph.D., of Texas Biomed. "One of the key observations was that the therapy continued to suppress virus levels for months after therapy was stopped. The current therapy for HBV infection targets the virus and works very well at suppressing viral replication and delaying progression of liver disease, but it is a lifelong therapy that does not provide a cure. "This GS-9620 therapy represents the first conceptually new treatment for HBV in more than a decade, and combining it with the existing antiviral therapy could be transformative in dealing with this disease," stated Lanford. The Gilead drug binds a receptor called Toll-Like Receptor 7 that is present in immune cells. The receptor normally recognizes invading viruses and triggers the immune system to suppress viral replication by the innate immune response and kill infected cells by the adaptive immune response, thus orchestrating both arms of the immune system. HBV damages the liver, leading to cirrhosis and liver cancer. Liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer death. According to the United States Centers for Disease Control and Prevention (CDC), up to 1.4 million Americans are chronically infected with HBV. The World Health Organization estimates that two billion people have been infected with the hepatitis B virus, resulting in more than 240 million people with chronic infections and 620,000 deaths every year. ### About Gilead Sciences Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, Calif., Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit the company's website at http://www.gilead.com. About Texas Biomed Texas Biomed, formerly the Southwest Foundation for Biomedical Research, is one of the world's leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. Located on a 200-acre campus on the northwest side of San Antonio, Texas, the Institute partners with hundreds of researchers and institutions around the world, targeting advances in the fight against AIDS, hepatitis, malaria, parasitic infections and a host of other infectious diseases, as well as cardiovascular disease, diabetes, obesity, cancer, psychiatric disorders, and problems of pregnancy. For more information on Texas Biomed, go to http://www.TxBiomed.org, or call Joe Carey, Texas Biomed's Vice President for Public Affairs, at 210-258-9437.


ELSE PRESS RELEASES FROM THIS DATE:

Hitting 'reset' in protein synthesis restores myelination

2013-04-27
BUFFALO, N.Y. –A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England. The institute is the research arm of the Hunter's Hope Foundation, established in 1997 by Jim Kelly, Buffalo Bills Hall of Fame quarterback, and his wife, Jill, after their infant son Hunter was diagnosed with Krabbe Leukodystrophy, an inherited fatal disorder of the nervous system. Hunter died in 2005 at ...

Physicists, biologists unite to expose how cancer spreads

2013-04-27
Cancer cells that can break out of a tumor and invade other organs are more aggressive and nimble than nonmalignant cells, according to a new multi-institutional nationwide study. These cells exert greater force on their environment and can more easily maneuver small spaces. The researchers report in the journal Scientific Reports that a systematic comparison of metastatic breast-cancer cells to healthy breast cells revealed dramatic differences between the two cell lines in their mechanics, migration, oxygen response, protein production and ability to stick to surfaces. ...

GW Cancer Institute publishes research on challenges faced by adolescent cancer survivors

2013-04-27
WASHINGTON (April 26, 2013) – New research out of the George Washington University Cancer Institute (GWCI) focuses on the difficulties of transitioning to adulthood while dealing with the long-term and late effects of cancer and its treatment. The study was recently published in the Journal of Oncology Navigation and Survivorship, titled "Improving Cancer Survivorship for Adolescents and Adults." Based on information obtained at GWCI's second Cancer Survivorship Research Symposium, the paper summarizes the discussion amongst cancer survivors, caregivers, researchers, ...

New approaches in treating complicated childhood polycystic kidney disease

2013-04-27
A collaborative team of physician-scientists at the Medical College of Wisconsin (MCW) and Children's Hospital of Wisconsin Research Institute has developed a new evidence-based, clinical algorithm to help physicians treat complex patients with autosomal recessive polycystic kidney disease (ARPKD). Their invited manuscript, written by Grzegorz Telega, M.D., associate professor of pediatrics (gastroenterology and hepatology) at MCW and program director of hepatology at Children's Hospital of Wisconsin; David Cronin, II, M.D., Ph.D., professor of surgery and ...

Create a new financial plan following a Nebraska divorce

2013-04-27
Create a new financial plan following a Nebraska divorce Article provided by Thompson Law Office, PC, LLO Visit us at http://www.thenebraskalawfirm.com In a Nebraska divorce, the marital assets are divided equitably between the spouses. In addition to the property settlement, in some cases one spouse may receive alimony, which provides continued support when the economic circumstances of the parties make it appropriate. When considering whether alimony is necessary, the court reviews the length of the marriage, contributions of each party, including childcare ...

Documentary looks at children's perspective in divorce

2013-04-27
Documentary looks at children's perspective in divorce Article provided by Thompson Law Office, PC, LLO Visit us at http://www.thenebraskalawfirm.com One of the biggest worries for parents going through divorce is how their children will adjust. For children the uncertainty of where they will be living and less time with each parent is frightening. In divorce, the voices of the children can become lost. A new documentary asks children to explain in their own words how they have been affected by the divorce of their parents. The film, scheduled to be released ...

Multiple vehicle accidents on the New Jersey Turnpike cause injuries

2013-04-27
Multiple vehicle accidents on the New Jersey Turnpike cause injuries Article provided by Brenner & Levine, P.A. Visit us at http://www.bllawnj.com The New Jersey Turnpike is notorious for motor vehicle crashes. With the high number of cars and trucks on the roads each day, car crashes are a common occurrence in the state. A single vehicle accident can cause hours-long traffic delays on the turnpike during rush hour. When multiple vehicles are involved, personal injuries and wrongful deaths often result from the ensuing mess that is created. In mid-April, ...

Are workers eligible for work comp benefits after motor vehicle accidents?

2013-04-27
Are workers eligible for work comp benefits after motor vehicle accidents? Article provided by Terry Katz & Associates, P.C. Visit us at http://www.terrykatzandassociates.com When most people consider an on-the-job injury, they likely envision dangerous factory floors with large machinery. Despite these preconceived notions, some of the most dangerous jobs in the country are actually those that require the worker to spend a significant amount of time driving. In fact, among the top 10 deadliest occupations in the United States are truck drivers, sales representatives ...

Estate planning issues for same-sex couples in Florida

2013-04-27
Estate planning issues for same-sex couples in Florida Article provided by Barreto & Romero, P.A. Visit us at http://www.miamiprobate.com In the tumultuous legal and political landscape surrounding the ongoing same-sex marriage debate, Florida's LGBT couples still face a number of estate planning obstacles not shared by their heterosexual counterparts. While not everyone is comfortable discussing or even contemplating the prospect of growing old and dying, it is especially important for same-sex partners to address these issues head on in order to protect the ...

Doctors' protections under Massachusetts "apology" law are limited

2013-04-27
Doctors' protections under Massachusetts "apology" law are limited Article provided by Adler, Cohen, Harvey, Wakeman and Guekguezian, L.L.P. Visit us at http://www.adlercohen.com/ In November 2012, the Health Payment Reform Act went into effect in Massachusetts. Widely heralded by supporters, the new law was intended to help reduce health care costs and improve the quality of health care available in Massachusetts. One of the most highly publicized aspects of the new law, however, may also be among the least understood. Disclosure, Apology and Offer A ...

LAST 30 PRESS RELEASES:

New discovery reveals the spinal cord’s role in bladder control

Kākāpō decline reveals threat of parasite coextinction

Astrocytes identified as hidden culprit behind PTSD

Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer

European study offers clearer picture of childhood brain tumor survival

The Lancet: Three in five liver cancer cases due to preventable risk factors; obesity-linked cases on the rise, new analysis suggest

Tiny artificial cells can keep time, study finds

How aging quiets lupus and brings relief to some older patients

Research alert: Synergistic treatment approach supercharges cancer immunotherapy

White veteran high users of online portal generate and exchange more messages than certain patient minorities in the Veterans Health Administration

Web-based tool helps Michigan physicians navigate diabetes coverage and prior authorization

Most primary care patients with opioid use disorder who start treatment stay engaged

U.S.-born Latinos have higher rates of obesity compared to foreign-born Latino and white youth

Study finds veterans experiencing homelessness who gain housing are more likely to get colorectal and breast cancer screenings

Body fat percentage beats BMI in predicting 15-year mortality risk among U.S. adults ages 20 to 49

Umbrella review summarizes family physicians’ experiences with clinical integration

HEAL protocol addresses human trafficking in Brazilian primary care

Study finds uneven progress toward diabetes goals across patient groups in the enhanced primary care diabetes program

Veterans experiencing homelessness who secure housing more likely to get cancer health screenings

Family physicians improve rural maternity outcomes but those in high-need states need support

Tip sheet summaries Annals of Family Medicine July/August 2025

TFLN-based RGB multiplexer for energy-efficient laser beam scanning

On a Florida bombing range, endangered woodpeckers get a second chance

Study identifies gene clusters in rhizobia linked to robust legume growth

Remapping the evolutionary tree of butterflies

Employees who spot problems help the bottom line, so why do leaders give more power to bootlickers?

Could living near water mean you’ll live longer?

Alcohol withdrawal syndrome linked to worse surgical outcomes, higher costs

US POINTER trial: Structured lifestyle intervention delays cognitive decline

Detecting a potential behavioral biomarker for Parkinson’s disease in mice

[Press-News.org] New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection